Patanjali misleading ads case: Baba Ramdev, Acharya Balkrishna move Kerala Court to recall non-bailable warrant

On February 3, Kerala Court issued non-bailable warrants against Baba Ramdev and Acharya Balkrishna over alleged misleading advertisements linked to Divya Pharmacy, a subsidiary of Patanjali Ayurved.

By  Storyboard18Feb 6, 2025 4:45 PM
Patanjali misleading ads case: Baba Ramdev, Acharya Balkrishna move Kerala Court to recall non-bailable warrant
The arrest warrant was issued against Baba Ramdev and Acharya Balkrishna over them failing to attend a court hearing scheduled earlier this month.

Baba Ramdev and Acharya Balkrishna moved an application at a Kerala trial court to recall the non-bailable arrest warrants against them in the misleading advertisement case.

The Kerala court had issued non-bailable warrants on February 3, against the duo after their failure to appear in a criminal case linked to allegedly misleading advertisements by Divya Pharmacy, a subsidiary of Patanjali Ayurved.

Ramdev and Balkrishna reportedly have filed the application under Section 205 of the Code of Criminal Procedure (CrPC), which deals with the trial courts' discretion to exempt accused persons from having to personally appear for court hearings and instead be represented by lawyers.

The warrants were issued by the Judicial First Class Magistrate-II in Palakkad to secure their attendance on February 15. Earlier, the court had ordered bailable warrants for the duo, instructing them to appear on February 1. Their absence on that date prompted the escalation to non-bailable warrants.

The case stems from a complaint filed by Kerala’s Drugs Inspector, who accuses Divya Pharmacy of violating provisions of The Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954. Specifically, the complaint cites violations of Sections 3, 3(b), and 3(d), which prohibit advertising certain drugs for specific diseases, sexual enhancement claims, and unsubstantiated health benefits.

In this legal proceeding, Divya Pharmacy is named as the first accused, with Acharya Balkrishna and Baba Ramdev listed as the second and third accused, respectively.

This is not the first time Patanjali Ayurved has faced legal scrutiny for its marketing practices. The company came under fire for publishing advertisements that allegedly disparaged modern medicine, particularly Allopathy. The Supreme Court previously issued a contempt notice against Patanjali for continuing to run such ads, but the case was later closed after Ramdev, Balkrishna, and Patanjali offered a public apology.


Tags
First Published on Feb 6, 2025 4:45 PM

More from Storyboard18

How it Works

YouTube to invest Rs 850 crore into Indian creators: Neal Mohan

YouTube to invest Rs 850 crore into Indian creators: Neal Mohan

How it Works

AI is advertising’s most profound revolution yet: WPP's Mark Read

AI is advertising’s most profound revolution yet: WPP's Mark Read

Advertising

Microsoft's news ad revenue sees 18% rise, revenue up 16% in Q1 2025

Microsoft's news ad revenue sees 18% rise, revenue up 16% in Q1 2025

Advertising

Zomato's ad expenses up by 63% to Rs 634 crore, profit declines to Rs 39 crore in Q4 FY25

Zomato's ad expenses up by 63% to Rs 634 crore, profit declines to Rs 39 crore in Q4 FY25

How it Works

Sundar Pichai to testify in Google search antitrust trial

Sundar Pichai to testify in Google search antitrust trial

Advertising

Remember the times when ZooZoos were all the rage?

Remember the times when ZooZoos were all the rage?

Advertising

DOOH emerges as new growth engine for state advertising revenues

DOOH emerges as new growth engine for state advertising revenues

Advertising

FSSAI challenges Dabur's '100% Juice' claim in Delhi High Court

FSSAI challenges Dabur's '100% Juice' claim in Delhi High Court